Progyny (PGNY) Stock Forecast, Price Target & Predictions
PGNY Stock Forecast
Progyny stock forecast is as follows: an average price target of $29.00 (represents a 91.42% upside from PGNY’s last price of $15.15) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
PGNY Price Target
The average price target for Progyny (PGNY) is $29.00 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $41.00 to $18.00. This represents a potential 91.42% upside from PGNY's last price of $15.15.
PGNY Analyst Ratings
According to 9 Wall Street analysts, Progyny's rating consensus is 'Hold'. The analyst rating breakdown for PGNY stock is 0 'Strong Buy' (0.00%), 3 'Buy' (33.33%), 6 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Progyny Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 20, 2024 | Richard Close | Canaccord Genuity | $18.00 | $16.46 | 9.36% | 18.81% |
| Sep 20, 2024 | Michael Cherny | Bank of America Securities | $22.00 | $16.46 | 33.66% | 45.21% |
| Sep 19, 2024 | Glen Santangelo | Jefferies | $24.00 | $16.55 | 45.01% | 58.42% |
| Sep 19, 2024 | Jailendra Singh | Truist Financial | $33.00 | $17.78 | 85.64% | 117.82% |
| Aug 07, 2024 | Richard Close | Canaccord Genuity | $24.00 | $25.74 | -6.76% | 58.42% |
| Jul 16, 2024 | Constantine Davides | JMP Securities | $36.00 | $29.03 | 24.01% | 137.62% |
| May 17, 2024 | Jailendra Singh | Truist Financial | $37.00 | $27.55 | 34.30% | 144.22% |
| May 10, 2024 | David Larsen | BTIG | $41.00 | $32.50 | 26.15% | 170.63% |
The latest Progyny stock forecast, released on Sep 20, 2024 by Richard Close from Canaccord Genuity, set a price target of $18.00, which represents a 9.36% increase from the stock price at the time of the forecast ($16.46), and a 18.81% increase from PGNY last price ($15.15).
Progyny Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 5 | 8 |
| Avg Price Target | - | $24.20 | $29.38 |
| Last Closing Price | $15.15 | $15.15 | $15.15 |
| Upside/Downside | -100.00% | 59.74% | 93.93% |
In the current month, the average price target of Progyny stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Progyny's last price of $15.15. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 20, 2024 | Truist Financial | Market Perform | Market Perform | Hold |
| Sep 20, 2024 | SVB Leerink | Underperform | Underperform | Hold |
| Sep 20, 2024 | Canaccord Genuity | Hold | Hold | Hold |
| Sep 20, 2024 | Bank of America Securities | Buy | Buy | Hold |
| Sep 19, 2024 | Jefferies | Buy | Buy | Hold |
| Sep 19, 2024 | JMP Securities | Underperform | Market Perform | Downgrade |
| Aug 07, 2024 | Raymond James | Market Perform | Market Perform | Hold |
| Aug 07, 2024 | BTIG | Buy | Neutral | Downgrade |
| Aug 07, 2024 | Canaccord Genuity | - | Reduce | Downgrade |
| Aug 06, 2024 | Jefferies | Buy | Buy | Hold |
Progyny's last stock rating was published by Truist Financial on Sep 20, 2024. The company gave PGNY a "Market Perform" rating, the same as its previous rate.
Progyny Financial Forecast
Progyny Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $269.94M | $280.89M | $279.37M | $258.39M | $214.32M | $205.37M | $195.00M | $172.22M | $127.55M | $122.28M | $128.65M | $122.13M | $100.30M | $98.93M | $64.61M | $81.02M | $65.12M | $61.20M |
| Avg Forecast | $359.10M | $358.69M | $367.00M | $348.53M | $298.88M | $301.46M | $307.80M | $288.61M | $292.69M | $296.85M | $305.11M | $289.41M | $274.08M | $271.20M | $261.91M | $246.43M | $211.78M | $194.54M | $190.51M | $167.18M | $134.63M | $126.72M | $129.29M | $121.45M | $97.86M | $92.54M | $48.30M | $71.81M | $66.07M | $60.83M |
| High Forecast | $359.10M | $358.69M | $367.00M | $348.53M | $298.88M | $301.46M | $307.80M | $288.61M | $292.69M | $300.76M | $305.21M | $289.41M | $275.88M | $271.20M | $261.91M | $246.43M | $211.78M | $194.54M | $190.51M | $167.18M | $134.63M | $126.72M | $129.29M | $121.45M | $97.86M | $92.54M | $48.30M | $71.81M | $66.07M | $60.83M |
| Low Forecast | $359.10M | $358.69M | $367.00M | $348.53M | $298.88M | $301.46M | $307.80M | $288.61M | $292.69M | $292.41M | $305.00M | $289.41M | $272.09M | $271.20M | $261.91M | $246.43M | $211.78M | $194.54M | $190.51M | $167.18M | $134.63M | $126.72M | $129.29M | $121.45M | $97.86M | $92.54M | $48.30M | $71.81M | $66.07M | $60.83M |
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | 1.04% | 1.07% | 1.05% | 1.01% | 1.06% | 1.02% | 1.03% | 0.95% | 0.97% | 1.00% | 1.01% | 1.02% | 1.07% | 1.34% | 1.13% | 0.99% | 1.01% |
Progyny's average Quarter revenue forecast for Mar 24 based on 3 analysts is $289.41M, with a low forecast of $289.41M, and a high forecast of $289.41M. PGNY's average Quarter revenue forecast represents a 7.21% increase compared to the company's last Quarter revenue of $269.94M (Dec 23).
Progyny EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $13.80M | $18.19M | $15.18M | $15.55M | $3.75M | $11.26M | $9.22M | $306.00K | $1.00K | $9.53M | $12.47M | $12.20M | $1.41M | $5.80M | $-1.35M | $4.84M | $-3.80M | $-7.65M |
| Avg Forecast | $22.87M | $22.84M | $23.37M | $22.19M | $19.03M | $19.20M | $19.60M | $18.38M | $18.64M | $18.90M | $19.43M | $552.33K | $17.45M | $17.27M | $16.68M | $590.73K | $2.94M | $12.39M | $12.13M | $631.80K | $8.57M | $8.07M | $11.50M | $7.73M | $6.23M | $5.89M | $3.08M | $5.33M | $4.21M | $3.87M |
| High Forecast | $22.87M | $22.84M | $23.37M | $22.19M | $19.03M | $19.20M | $19.60M | $18.38M | $18.64M | $19.15M | $19.44M | $662.80K | $17.57M | $17.27M | $16.68M | $708.88K | $3.53M | $12.39M | $12.13M | $758.16K | $8.57M | $8.07M | $13.80M | $7.73M | $6.23M | $5.89M | $3.08M | $6.39M | $4.21M | $3.87M |
| Low Forecast | $22.87M | $22.84M | $23.37M | $22.19M | $19.03M | $19.20M | $19.60M | $18.38M | $18.64M | $18.62M | $19.42M | $441.87K | $17.33M | $17.27M | $16.68M | $472.59K | $2.35M | $12.39M | $12.13M | $505.44K | $8.57M | $8.07M | $9.20M | $7.73M | $6.23M | $5.89M | $3.08M | $4.26M | $4.21M | $3.87M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.79% | 1.05% | 0.91% | 26.33% | 1.27% | 0.91% | 0.76% | 0.48% | 0.00% | 1.18% | 1.08% | 1.58% | 0.23% | 0.98% | -0.44% | 0.91% | -0.90% | -1.97% |
3 analysts predict PGNY's average Quarter EBITDA for Mar 24 to be $552.33K, with a high of $662.80K and a low of $441.87K. This is -96.00% lower than Progyny's previous annual EBITDA (Dec 23) of $13.80M.
Progyny Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $13.47M | $15.90M | $14.99M | $17.68M | $3.41M | $13.21M | $8.77M | $4.97M | $15.08M | $16.80M | $18.73M | $15.17M | $38.86M | $5.36M | $-1.81M | $4.06M | $-4.40M | $-8.21M |
| Avg Forecast | $19.57M | $21.52M | $21.52M | $21.52M | $16.52M | $17.70M | $18.81M | $17.64M | $14.09M | $13.99M | $16.57M | $11.73M | $10.51M | $11.22M | $10.06M | $12.55M | $81.11M | $2.94M | $1.22M | $13.42M | $3.52M | $6.09M | $17.28M | $8.87M | $6.30M | $5.03M | $-2.37M | $4.46M | $998.65K | $1.96M |
| High Forecast | $19.57M | $21.52M | $21.52M | $21.52M | $16.52M | $17.70M | $18.81M | $17.64M | $14.09M | $14.37M | $16.59M | $14.08M | $12.85M | $11.23M | $10.06M | $15.06M | $97.33M | $2.94M | $1.22M | $16.11M | $3.52M | $6.09M | $20.73M | $8.87M | $6.30M | $5.03M | $-2.37M | $5.36M | $998.65K | $1.96M |
| Low Forecast | $19.57M | $21.52M | $21.52M | $21.52M | $16.52M | $17.70M | $18.81M | $17.64M | $14.09M | $13.23M | $16.55M | $9.39M | $8.18M | $11.20M | $10.06M | $10.04M | $64.89M | $2.94M | $1.22M | $10.74M | $3.52M | $6.09M | $13.82M | $8.87M | $6.30M | $5.03M | $-2.37M | $3.57M | $998.65K | $1.96M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.28% | 1.42% | 1.49% | 1.41% | 0.04% | 4.50% | 7.17% | 0.37% | 4.28% | 2.76% | 1.08% | 1.71% | 6.17% | 1.06% | 0.77% | 0.91% | -4.41% | -4.20% |
Progyny's average Quarter net income forecast for Mar 24 is $11.73M, with a range of $9.39M to $14.08M. PGNY's average Quarter net income forecast represents a -12.89% decrease compared to the company's last Quarter net income of $13.47M (Dec 23).
Progyny SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $43.09M | $44.44M | $45.46M | $43.63M | $41.19M | $34.74M | $35.05M | $33.01M | $25.30M | $19.43M | $17.96M | $17.10M | $19.72M | $15.47M | $13.78M | $12.74M | $10.63M | $9.25M |
| Avg Forecast | $60.30M | $60.23M | $61.62M | $58.52M | $50.19M | $50.62M | $51.68M | $48.46M | $49.15M | $49.84M | $51.23M | $77.91M | $46.02M | $45.54M | $43.98M | $83.33M | $41.16M | $32.66M | $31.99M | $89.12M | $22.61M | $21.28M | $16.57M | $20.39M | $16.43M | $15.54M | $8.11M | $14.02M | $11.09M | $10.21M |
| High Forecast | $60.30M | $60.23M | $61.62M | $58.52M | $50.19M | $50.62M | $51.68M | $48.46M | $49.15M | $50.50M | $51.25M | $93.49M | $46.32M | $45.54M | $43.98M | $99.99M | $49.39M | $32.66M | $31.99M | $106.94M | $22.61M | $21.28M | $19.89M | $20.39M | $16.43M | $15.54M | $8.11M | $16.82M | $11.09M | $10.21M |
| Low Forecast | $60.30M | $60.23M | $61.62M | $58.52M | $50.19M | $50.62M | $51.68M | $48.46M | $49.15M | $49.10M | $51.21M | $62.33M | $45.69M | $45.54M | $43.98M | $66.66M | $32.93M | $32.66M | $31.99M | $71.30M | $22.61M | $21.28M | $13.26M | $20.39M | $16.43M | $15.54M | $8.11M | $11.21M | $11.09M | $10.21M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 0.98% | 1.03% | 0.52% | 1.00% | 1.06% | 1.10% | 0.37% | 1.12% | 0.91% | 1.08% | 0.84% | 1.20% | 1.00% | 1.70% | 0.91% | 0.96% | 0.91% |
Progyny's average Quarter SG&A projection for Mar 24 is $77.91M, based on 3 Wall Street analysts, with a range of $62.33M to $93.49M. The forecast indicates a 80.79% rise compared to PGNY last annual SG&A of $43.09M (Dec 23).
Progyny EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.13 | $0.17 | $0.16 | $0.19 | $0.04 | $0.14 | $0.10 | $0.05 | $0.17 | $0.19 | $0.21 | $0.17 | $0.45 | $0.06 | $-0.02 | $0.05 | $-0.07 | $-0.10 |
| Avg Forecast | $0.20 | $0.22 | $0.22 | $0.22 | $0.17 | $0.18 | $0.19 | $0.18 | $0.14 | $0.14 | $0.17 | $0.13 | $0.11 | $0.11 | $0.10 | $0.07 | $0.01 | $0.03 | $0.01 | $-0.02 | $0.04 | $0.06 | $0.08 | $0.09 | $0.06 | $0.05 | $-0.02 | $0.02 | $0.01 | $0.02 |
| High Forecast | $0.20 | $0.22 | $0.22 | $0.22 | $0.17 | $0.18 | $0.19 | $0.18 | $0.14 | $0.15 | $0.17 | $0.13 | $0.13 | $0.11 | $0.10 | $0.07 | $0.01 | $0.03 | $0.01 | $-0.02 | $0.04 | $0.06 | $0.08 | $0.09 | $0.06 | $0.05 | $-0.02 | $0.02 | $0.01 | $0.02 |
| Low Forecast | $0.20 | $0.22 | $0.22 | $0.22 | $0.17 | $0.18 | $0.19 | $0.18 | $0.14 | $0.14 | $0.17 | $0.13 | $0.08 | $0.11 | $0.10 | $0.07 | $0.01 | $0.03 | $0.01 | $-0.02 | $0.04 | $0.06 | $0.08 | $0.09 | $0.06 | $0.05 | $-0.02 | $0.02 | $0.01 | $0.02 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.21% | 1.48% | 1.56% | 2.56% | 3.43% | 4.67% | 8.00% | -3.00% | 4.72% | 3.05% | 2.52% | 1.88% | 6.99% | 1.17% | 0.83% | 2.07% | -6.86% | -5.00% |
According to 3 Wall Street analysts, Progyny's projected average Quarter EPS for Mar 24 is $0.13, with a low estimate of $0.13 and a high estimate of $0.13. This represents a 1.77% increase compared to PGNY previous annual EPS of $0.13 (Dec 23).
Progyny Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TDOC | Teladoc Health | $8.87 | $50.87 | 473.51% | Hold |
| HCAT | Health Catalyst | $7.68 | $29.25 | 280.86% | Buy |
| GDRX | GoodRx | $5.87 | $14.57 | 148.21% | Buy |
| DH | Definitive Healthcare | $4.08 | $9.50 | 132.84% | Hold |
| SLP | Simulations Plus | $27.49 | $56.00 | 103.71% | Buy |
| CERT | Certara | $10.25 | $20.60 | 100.98% | Buy |
| PHR | Phreesia | $18.46 | $36.31 | 96.70% | Buy |
| PGNY | Progyny | $15.15 | $29.00 | 91.42% | Hold |
| EVH | Evolent Health | $23.36 | $43.00 | 84.08% | Buy |
| TXG | 10x Genomics | $16.78 | $30.20 | 79.98% | Hold |
| PRVA | Privia Health Group | $19.22 | $33.82 | 75.96% | Buy |
| VEEV | Veeva Systems | $212.53 | $229.71 | 8.08% | Buy |
| HSTM | HealthStream | $29.17 | $29.00 | -0.58% | Buy |
PGNY Forecast FAQ
Is Progyny a good buy?
No, according to 9 Wall Street analysts, Progyny (PGNY) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 33.33% of PGNY's total ratings.
What is PGNY's price target?
Progyny (PGNY) average price target is $29 with a range of $18 to $41, implying a 91.42% from its last price of $15.15. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Progyny stock go up soon?
According to Wall Street analysts' prediction for PGNY stock, the company can go up by 91.42% (from the last price of $15.15 to the average price target of $29), up by 170.63% based on the highest stock price target, and up by 18.81% based on the lowest stock price target.
Can Progyny stock reach $20?
PGNY's average twelve months analyst stock price target of $29 supports the claim that Progyny can reach $20 in the near future.
What are Progyny's analysts' financial forecasts?
Progyny's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.2B (high $1.2B, low $1.2B), average EBITDA is $76.21M (high $76.21M, low $76.21M), average net income is $70.66M (high $70.66M, low $70.66M), average SG&A $200.95M (high $200.95M, low $200.95M), and average EPS is $0.722 (high $0.722, low $0.722). PGNY's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.43B (high $1.43B, low $1.43B), average EBITDA is $91.27M (high $91.27M, low $91.27M), average net income is $84.14M (high $84.14M, low $84.14M), average SG&A $240.67M (high $240.67M, low $240.67M), and average EPS is $0.86 (high $0.86, low $0.86).
Did the PGNY's actual financial results beat the analysts' financial forecasts?
Based on Progyny's last annual report (Dec 2023), the company's revenue was $1.09B, beating the average analysts forecast of $1.05B by 3.32%. Apple's EBITDA was $62.18M, beating the average prediction of $51.99M by 19.60%. The company's net income was $62.04M, beating the average estimation of $44.34M by 39.92%. Apple's SG&A was $176.62M, missing the average forecast of $218.86M by -19.30%. Lastly, the company's EPS was $0.62, beating the average prediction of $0.399 by 55.33%. In terms of the last quarterly report (Dec 2023), Progyny's revenue was $269.94M, missing the average analysts' forecast of $274.08M by -1.51%. The company's EBITDA was $13.8M, missing the average prediction of $17.45M by -20.93%. Progyny's net income was $13.47M, beating the average estimation of $10.51M by 28.12%. The company's SG&A was $43.09M, missing the average forecast of $46.02M by -6.36%. Lastly, the company's EPS was $0.13, beating the average prediction of $0.107 by 20.98%